Drugs giant GSK set to sell rare diseases business to step up efficiency drive
DRUGS giant GlaxoSmithKline plans to narrow its research and could sell its rare diseases business as it steps up an efficiency drive under new chief executive, Emma Walmsley.
Daily Express :: Finance Feed
Comments are closed.